Neurothrombectomy Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Neurothrombectomy Devices Market is Segmented by Product (Clot Retrievers, Suction Devices, and Vascular Snares), End User (Hospitals, Ambulatory Surgical Centers, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value in USD million for the above-mentioned segments.

Neurothrombectomy Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Neurothrombectomy Devices Industry Overview

The neurothrombectomy devices market is highly competitive in nature, with many key players dominating the market. The presence of major market players, such as Abbott Laboratories, Johnson & Johnson, Medtronic, Stryker, and Vesalio, is intensifying the competition. The market players are adopting strategies, such as R&D, mergers, acquisitions, and product innovations, to sustain the increasing market rivalry.

In April 2019, Medtronic launched its fourth-generation Solitaire X revascularization device for AIS treatment.

Neurothrombectomy Devices Market Leaders

  1. Medtronic

  2. Stryker

  3. Siemens Healthineers

  4. Acandis

  5. INARI Medical

  6. *Disclaimer: Major Players sorted in no particular order
Medtronic, Stryker, Siemens Healthineers, Acandis, INARI Medical

Neurothrombectomy Devices Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?